Multiple Sclerosis Awareness Week – shining a light on unmet needs  

Vast strides have been made in multiple sclerosis (MS) treatment and care in recent years. Despite these advancements, unmet needs remain for people living with this lifelong condition that can severely impact many aspects of their lives. MS Brain Health – time matters 2024, published this week in Multiple Sclerosis and Related Disorders, presents expert consensus recommendations to address these ongoing needs and transform MS care globally.

MS is an incurable chronic disease affecting 2.8 million people worldwide and is the leading cause of non-traumatic neurological disability in young adults. Oxford PharmaGenesis has had the privilege of working with the not-for-profit organization, Oxford Health Policy Forum, on two long-term initiatives aimed at supporting people with MS to live their best possible lives – MS Brain Health and triMS.online. As HealthScience professionals, we can play our part in advancing care. These may include helping convene experts to understand the precise needs of people affected by a condition, collaborating with diverse experts to formulate evidence-based policy recommendations to ensure scientific advancements are translated into improvements in care, and raising awareness of the changes needed among key stakeholders.

This MS Awareness Week, we shine a light on the 2024 MS Brain Health report recommendations and echo the authors in urging all stakeholders to ‘move beyond if only and seize opportunities for meaningful change’.

We also look at how triMS.online is working to enhance patient care globally by providing a platform for sharing knowledge and best practices among healthcare professionals (HCPs).

Join us this MS Awareness Week in advocating for better MS care. Read the 2024 MS Brain Health recommendations, support triMS.online, and help us make a difference.